Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-na & #239;ve and experienced patients with chronic hepatitis B

Conclusion: Both ETV and TDF therapy resulted in a high CVR, and the annual incidence rates of HCC and other cirrhosis-related complications were not significantly different between the two treatment groups.

Source: The Saudi Journal of Gastroenterology - November 19, 2018 Category: Gastroenterology Authors: Young Min Kim Hyun Phil Shin Joung Il Lee Kwang Ro Joo Jae Myung Cha Jung Won Jeon Jin Young Yoon Min Seob Kwak Source Type: research